Lv41
590 积分 2025-07-16 加入
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
31分钟前
已完结
Biosimilars approved for hematology use: lessons from comparative efficacy studies and comparative analytical assessments
3个月前
已关闭
Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis
4个月前
已关闭
Assessing Drug Efficacy After Multiple Negative Trials—Gepirone’s Journey Through the FDA
4个月前
已完结
Social Functioning
6个月前
已完结
Heterogeneity of outcome measures in depression trials and the relevance of the content of outcome measures to patients: a systematic review
6个月前
已完结
Not sad enough for a depression trial? A systematic review of depression measures and cut points in clinical trial registrations
6个月前
已完结
Assessment of the Efficacy and Safety of BMS-820836 in Patients With Treatment-Resistant Major Depression
8个月前
已完结
5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects
9个月前
已完结
Macrophage polarization regulates the pathogenesis and progression of autoimmune diseases
10个月前
已完结